A blunted cortisol awakening response and hippocampal atrophy in type 2 diabetes mellitus
Introduction
In recent years, the cortisol awakening response (CAR) has been increasingly used as an index of adrenocortical activity in psychiatric and non-psychiatric populations. The characteristics of the CAR are well-described; it represents a rise in cortisol of 50–75% with peak levels about 30 min post-wake-up (Clow et al., 2004). However, the underlying regulatory mechanisms for this post-wake-up response remain unclear. More is known about the impact of various factors, such as age, gender, oral contraceptive use, menstrual cycle phase, wake-up time, and smoking status on the CAR, but results have not been uniform. Briefly, increasing age has been associated with an attenuated CAR (Kudielka and Kirschbaum, 2003), albeit not consistently (Pruessner et al., 1997). There are some gender-based differences in CAR, with women maintaining higher cortisol levels after peak levels have been reached (Pruessner et al., 1997, Wuest et al., 2000, Schlotz et al., 2004). However, menstrual cycle phase and oral contraceptive use do not seem to impact the CAR (Kirschbaum et al., 1999). Findings with respect to the impact of wake-up time on CAR appear mixed, with earlier wake-up times correlating with a higher CAR in some (Kudielka and Kirschbaum, 2003, Federenko et al., 2004), but not all (Pruessner et al., 1997, Hucklebridge et al., 1999) studies. Similarly, smoking has been shown to either have no effect on the CAR (Pruessner et al., 1997) or result in an increased CAR (Badrick et al., 2007). Please see Fries et al. (in press) for a review on the CAR.
In addition to the above-mentioned factors associated with the CAR, in the last few years a link between hippocampal integrity and the CAR has been postulated. For example, among healthy individuals smaller hippocampal volume is associated with a reduced CAR (Pruessner et al., 2005, Pruessner et al., 2007). Furthermore, patients with selective hippocampal lesions (Buchanan et al., 2004) and patients with severe global amnesia caused by damage in the frontal and temporal lobes (Wolf et al., 2005) exhibit a blunted CAR. However, the study of hippocampal lesion patients failed to find a direct association between hippocampal volume (assessed with MRI) and the CAR, and the study of global amnesia patients did not assess hippocampal volumes.
In psychiatric conditions such as depression and PTSD, both hippocampal volume loss (Videbech and Ravnkilde, 2004, Smith, 2005) and blunting of the CAR (Rohleder et al., 2004, Huber et al., 2006) have been reported. However, none of these studies conducted both CAR and hippocampal volume assessments in the same set of study subjects, which does not allow any comment on possible associations. Nevertheless, by considering the results of studies in healthy individuals together with those of lesion populations and the indirect evidence among psychiatric populations, some authors have suggested that hippocampal integrity per se may be crucial for an intact CAR. However, it remains unclear how milder forms of hippocampal atrophy, as have been described in type 2 diabetes mellitus (T2DM), impact on the CAR.
T2DM is a metabolic disorder, characterized by insulin resistance and hyperglycemia (Quinn, 2002). Risk factors for developing T2DM include age (Panagiotakos et al., 2008), physical inactivity (Dyck et al., 2008), obesity (Ferrannini et al., 1997) and genetic predisposition (Busch and Hegele, 2001). T2DM is associated with lipid abnormalities (Goldberg and Capuzzi, 2001), hypertension (Bloomgarden, 2001) and impairments in cognition (Awad et al., 2004). Importantly, there are two studies in the literature reporting hippocampal volume loss in T2DM (den Heijer et al., 2003, Gold et al., 2007). Given the role of the hippocampus in HPA axis feedback regulation (Jacobson and Sapolsky, 1991) and the close link between cortisol and glucose metabolism (Khani and Tayek, 2001), it is not all that surprising there is also some indication for HPA axis disturbances in T2DM, although the order of events remains unclear. Both unstimulated plasma levels (Lee et al., 1999), as well as dexamethasone-suppressed cortisol levels (Bruehl et al., 2007) have been shown to be elevated in T2DM, although this has not been uniformly reported (Andrews et al., 2002). In addition, elevated evening free cortisol salivary levels have been observed in T2DM relative to controls (Liu et al., 2005). Therefore, the purpose of this study was to ascertain the CAR and diurnal salivary cortisol profile in T2DM and determine whether it is associated to hippocampal volume.
Section snippets
Participants and procedure
30 volunteers (18 diabetics, 12 non-diabetic controls) participated in the study. They were referred by collaborating endocrinologists or responded to advertisements on the Internet. None had evidence of neurological, medical (except dyslipidemia, or hypertension), or psychiatric conditions. Head trauma, depression, and substance abuse were exclusion criteria. All participants came to our laboratory on 3 separate days and received a physical examination (see Bruehl et al., 2007) and an MRI scan
Medical
Diabetic participants tended to be younger (p = 0.076) and, as expected had significantly higher fasting glucose and insulin levels as well as higher percent HbA1c, greater BMI, and more lipid abnormalities than controls (all p < 0.05). Please refer to Table 1.
Salivary cortisol: CAR profile and diurnal profile
ANOVA of the CAR profile revealed a significant main effect of time (F = 5.063, p = 0.003), indicative of cortisol rhythmicity. Furthermore, we found a significant interaction of time and diagnosis for the CAR profile (F = 4.720, p = 0.004). The CAR
Discussion
In this first report of both CAR and hippocampal volume among individuals with T2DM and controls, we detected a blunting of the CAR, with preservation of diurnal rhythm, in participants with T2DM. In addition, as we had hypothesized, we found reduced hippocampal volume among individuals with T2DM and that reduction in hippocampal volume was associated with duration of T2DM, and long-term glycemic control (HbA1c). Furthermore, across all participants, insulin levels and hippocampal volume
Role of funding sources
This study was supported by grants DK 064087, P30-AG-08051 and NCRR M01 RR00096 from the National Institutes of Health, USA.
Conflict of interest
The authors have no real or apparent conflict of interest.
Acknowledgements
We thank Prof. Clemens Kirschbaum for conducting the cortisol assays.
References (52)
- et al.
Hypercortisolemia and hippocampal changes in depression
Psychiatry Res.
(1993) - et al.
Circadian regulation of cortisol after hippocampal damage in humans
Biol. Psychiatry
(2004) - et al.
Specific hippocampal volume reductions in individuals at risk for Alzheimer's disease
Neurobiol. Aging
(1997) - et al.
MRI volume of the amygdala: a reliable method allowing separation from the hippocampal formation
Psychiatry Res. Neuroimag.
(1999) - et al.
Volumetric analysis of the pre-frontal regions: findings in aging and schizophrenia
Psychiatry Res. Neuroimag.
(2001) Stress in the brain
Eur. J. Pharmacol.
(2000)- et al.
Free cortisol awakening responses are influenced by awakening time
Psychoneuroendocrinology
(2004) - et al.
Limbic system mechanisms of stress regulation: hypothalamo–pituitary–adrenocortical axis
Prog. Neuropsychopharmacol. Biol. Psychiatry
(2005) - et al.
The cortisol awakening response is blunted in psychotherapy inpatients suffering from depression
Psychoneuroendocrinology
(2006) - et al.
The awakening cortisol response and blood glucose levels
Life Sci.
(1999)